ÂÜÀòÂÒÂ×

Sangeeta Bhatia is a highly accomplished professional with a diverse background in academia and entrepreneurship. Currently serving as a Professor and Director at the Marble Center for Cancer Nanomedicine at Massachusetts Institute of Technology, Sangeeta is also involved in several start-up ventures including Matrisome Bio, Port Therapeutics, Satellite Bio, and Glympse Bio. With a strong academic foundation from Harvard Medical School, Massachusetts Institute of Technology, and Brown University, Sangeeta has made significant contributions in the fields of bioengineering and medicine. Additionally, Sangeeta has held key roles at organizations such as Vertex Pharmaceuticals, Hepregen, and the National Cancer Institute, showcasing their expertise and leadership in the scientific community.